oru.sePublikationer
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Screening for celiac disease in the general population and in high-risk groups
Orebro University Hospital. Orebro Univ Hosp, Dept Paediat, Orebro, Sweden.;Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden..
Univ Nottingham, Dept Epidemiol & Publ Hlth, Nottingham NG7 2RD, England..ORCID iD: 0000-0003-2555-2250
Univ Tampere, Sch Med, FIN-33101 Tampere, Finland.;Tampere Univ Hosp, Hosp, Dept Internal Med, Tampere, Finland.;Seinajoki Cent Hosp, Dept Internal Med, Seinajoki, Finland..
Univ Salvador, C Bonorino Udaondo Gastroenterol Hosp, Dept Med, Buenos Aires, DF, Argentina..
Show others and affiliations
2015 (English)In: United European Gastroenterology journal, ISSN 2050-6406, E-ISSN 2050-6414, Vol. 3, no 2, 106-120 p.Article, review/survey (Refereed) Published
Abstract [en]

Background: Celiac disease (CD) occurs in approximately 1% of the Western population. It is a lifelong disorder that is associated with impaired quality of life (QOL) and an excessive risk of comorbidity and death. Objectives: To review the literature on screening for CD in relation to the current World Health Organization (WHO) criteria for mass screening. Methods: We performed a PubMed search to identify indexed papers on CD screening with a publication date from 1900 until 1 June 2014. When we deemed an abstract relevant, we read the corresponding paper in detail. Results: CD fulfills several WHO criteria for mass screening (high prevalence, available treatment and difficult clinical detection), but it has not yet been established that treatment of asymptomatic CD may reduce the excessive risk of severe complications, leading to higher QOL nor that it is cost-effective. Conclusions: Current evidence is not sufficient to support mass screening for CD, but active case-finding may be appropriate, as we recognize that most patients with CD will still be missed by this strategy. Although proof of benefit is still lacking, screening for CD may be appropriate in high-risk groups.

Place, publisher, year, edition, pages
2015. Vol. 3, no 2, 106-120 p.
Keyword [en]
Celiac disease, gluten, gluten-free diet, review, screening, prevention, risk, quality of life, World Health Organization
National Category
Gastroenterology and Hepatology
Identifiers
URN: urn:nbn:se:oru:diva-56527DOI: 10.1177/2050640614561668ISI: 000352166700002PubMedID: 25922671OAI: oai:DiVA.org:oru-56527DiVA: diva2:1082658
Available from: 2017-03-17 Created: 2017-03-17 Last updated: 2017-03-20Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Ludvigsson, Jonas F.Card, Timothy R.Zingone, Fabiana
By organisation
Orebro University Hospital
In the same journal
United European Gastroenterology journal
Gastroenterology and Hepatology

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 48 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf